# Safety and Performance Evaluation of a Biological Matrix Used for Rectal Prolapse Repair by Ventral Rectopexy

> **NCT04130555** · — · COMPLETED · sponsor: **Meccellis Biotech** · enrollment: 55 (actual)

## Conditions studied

- Rectal Prolapse

## Interventions

- **DEVICE:** CELLIS Rectopexy (Porcine Acellular Dermal Matrix, PADM)

## Key facts

- **NCT ID:** NCT04130555
- **Lead sponsor:** Meccellis Biotech
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-11
- **Primary completion:** 2023-10-26
- **Final completion:** 2023-10-26
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2023-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04130555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04130555, "Safety and Performance Evaluation of a Biological Matrix Used for Rectal Prolapse Repair by Ventral Rectopexy". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04130555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*